IL25 and neoplasm: To address whether IL-25 expression plays a key role in the anti-metastatic activity of Q2-3 on mammary tumour cells, we further employed an antibody-neutralization approach to deplete the in vivo IL-25 activity in the same 4T1 tumour resection model.